【レポートの概要(一部)】
1. Report Overview
1.1 Overview of Findings: World Market Overview 2015 to 2026
1.2 Why You Should Read This Report
1.3 How This Report Delivers: Chapter Outlines
1.4 Main Questions Answered by This Analysis
1.5 Who is This Study For?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About visiongain
2. Introduction to Parkinson’s Disease and its Treatments
2.1 What Causes Parkinson’s?
2.2 Motor Symptoms of Parkinson’s Disease
2.2.1 Tremor: The First Sign of PD
2.2.2 Uncontrolled Muscle Contractions Cause Rigidity
2.2.3 Bradykinesia: The Most Characteristic Feature of Parkinson’s
2.2.4 Postural Instability Manifests as PD Progresses
2.3 Neuropsychiatric Symptoms are Common in PD Patients
2.3.1 Behavioural Deficits are Often the Most Widespread
2.3.2 Cognitive Impairment can Impede Daily Tasks
2.3.3 Autonomic Dysfunction: Another Common Occurrence
2.4 Other Symptoms Associated with Parkinson’s
2.5 Parkinson’s Disease: Diagnosis and Treatment
2.5.1 Diagnosis is Difficult
2.5.2 Treatment Options – Therapeutic Classes
3. Parkinson’s Disease: World Drugs Market, 2016-2026
3.1 Sales of the Overall World PD Drugs Market, 2015-2026
3.2 Parkinson’s Disease: Market Segmentation, 2015
3.3 Overall PD Drug Market: Commercial Drivers and Restraints
3.4 Dopaminergic Agents: Foundation of PD Treatment
3.4.1 Levodopa Therapy
3.4.2 Patent Expiries Affect the Market
3.4.3 New Levodopa Therapies on the Horizon
3.4.4 Dopaminergic Agents: Market Projections to 2026
3.5 Dopamine Receptor Agonists: The Leading Class in 2016
3.5.1 Dopamine Agonists: A Front Line Drug
3.5.2 Advantages over L-Dopa Therapy
3.5.3 Leading Drugs in the Segment
3.5.4 A Healthy R&D Pipeline
3.5.5 Dopamine Receptor Agonists: Market Projections, 2016-2026
3.6 Catechol-O-Methyl Transferase (COMT) Inhibitors: A Popular Choice of Treatment
3.6.1 Entacapone: The Leading Drug in this Segment
3.6.2 Commercial Scope for COMT Inhibitors
3.6.3 COMT Inhibitors: Market Projections, 2016-2026
3.7 Are Monoamine Oxidase–B (MAO-B) Inhibitors Better Than COMT?
3.7.1 MAO-B Inhibitor Therapeutics in the Market
3.7.2 New MAO-B Products in Development
3.7.3 MAO-B Inhibitors: Market Projections, 2016-2026
3.7.4 Other Therapeutic Options: A Growing Opportunity
3.7.5 Generic Erosion in the PD Market
3.7.6 A Broad and Diverse Pharmaceutical Segment
3.7.7 Other Non-medication PD Therapies
3.7.8 The Pipeline Offers Disease Modifying Potential
3.7.9 Other Mechanisms of Action: Market Projections, 2016-2026
4. Leading Companies in the PD Drug Market, 2016
4.1 PD: Novartis sales of Stalevo/Comtan
4.1.1 Market Forecast for Comtan/Stalevo, 2016-2026
4.2 Teva’s Azilect: Past, Present and Future
4.2.1 Market Forecast for Azilect, 2015-2026
4.3 UCB’s Leading Neupro Patch Drug
4.3.1 Market Forecast for Neupro, 2016-2026
4.4 Other Market Players
5. The Leading National Markets, 2016-2026
5.1 Regional Breakdown of the World PD Drug Market, 2016
5.2 The World PD Drug Market: Regional Forecasts to 2026
5.3 The PD Drug Market in the US: The Largest Single National Market
5.3.1 Market Projections for the US, 2015-2026
5.4 The PD Drug Market in the Five Leading European National Markets (EU5), 2016-2026
5.4.1 Market Projections for the EU5, 2016-2026
5.4.2 EU5 Breakdown by Country, 2016
5.4.3 Market Projection for EU5 Countries, Regional Breakdown
5.4.4 Germany: The Largest EU5 Market
5.4.5 France: Strong Healthcare System – What’s Possible There?
5.4.6 UK’s Spending Restrictions Affect the PD Drugs Market
5.4.7 Spain – What Effects Will Austerity Have on PD Drug Sales?
5.4.8 The PD Drug Market in Italy: Rising and Ageing Population
5.5 Japan has the Highest Proportion of Over-65s in the World
5.5.1 Predictions for Japanese PD Drug Market, 2016-2026
5.6 PD Drug Market in Emerging Countries: Brazil, Russia, India and China (BRIC)
5.6.1 Breakdown of BRIC Revenues by Country, 2016
5.6.2 Market Projections for BRIC Nations’ PD Drug Sales, 2016-2026
5.6.3 Brazil’s Rapid Growth of the Pharma Market – What’s the Future?
5.6.4 Russia’s Healthcare Market Gives Generic Sales Opportunities
5.6.5 India: Generic Manufacturers Seek to Dominate the PD Market
5.6.6 China’s Ageing Population Stimulates Sales of PD-Treating Medicines
6. Research and Development for Treating Parkinson’s Disease
6.1 New Mechanisms of Action in the Late-Stage R&D Pipeline
6.2 Growing Potential of Marketed Products: Phase IV Studies
6.3 Phase III Clinical Products Promising Potential in the PD market
6.3.1 IPX203 (Impax Laboratories): The New Generation of Levodopa
6.3.2 Newron’s Safinamide Expected Launch in 2020
6.3.3 Pimavanserin: A First-in-Class Treatment for Parkinson’s Disease Psychosis
6.3.4 Istradefylline: A Promising A(2a) Receptor Antagonist
6.3.5 Termination of Preladenant, APromising A(2a) Receptor Antagonist
6.3.6 Levodopa/Carbidopa Intestinal Gel (LCIG)
6.3.7 Can Opicapone Compete with Existing COMT Inhibitors
6.3.8 Pitolisant: Addressing an Unmet Need
6.3.9 Northera: Oral Precursor of Norepinephrine
6.3.10 Targin by Mundipharm
6.3.11 Nurelinfor Levodopa-Induced Dyskinesia
6.3.12 SYN-115/120: Superior to Istradefylline?
6.4 Phase II PD Pipeline: Overview
6.4.1 Glutamatergic Drugs: Main Target for Pipeline Candidates
6.4.2 Fipamezole: Another Promising A(2a) Receptor Antagonist
6.4.3 CVT-301: A Novel Intrapulmonary Approach
6.4.4 DM-1992: Can Compete with Levodopa Reformulations?
6.4.5 The Accordion Pill Carbidopa/Levodopa by Intec Pharma
6.4.6 Orient Addresses Sialorrhoea
6.4.7 NH004: Formulated with a Muco-Adhesive Property
6.4.8 VR040: A Reformulation of Apomorphine
6.4.9 AVP-923: A Novel Approach for LID-PD
6.4.10 PD Giant Orion, Develop a New Levodopa Drug, ODM-101
6.4.11 News for NeuroDerm’s Reformulations
6.5 Phase I and Pre-clinical PD Pipeline: Overview
6.5.1 Vernalis’ A(2a) Receptor Antagonist Drug in Phase Ib/IIa
6.5.2 Sanofi Collaborates with The Michael J. Fox Foundation
6.5.3 UCL Show Exenatide Potential in Parkinson’s
6.5.4 Titan Pharmaceuticals Develop a Novel Platform
6.6 Neuroprotective Drugs Offer Hope
6.6.1 Phytopharm and Cogane Development
6.6.2 The Potential of Dietary Supplements
6.6.3 GCase Enzymes: Amicus and Biogen Strike A Deal for Parkinson’s
6.6.4 Research Finds Ursodeoxycholic Acid (UDCA) A Potential Cure for Parkinson’s
6.6.5 PD Biomarkers: Potential for Revolutionising Diagnosis and Treatment
6.6.6 Antibody Targeting: The Coming of Age
6.7 Gene Therapy: Promising Research and Technology
6.7.1 ProSavin: Leading Gene Therapy Product
6.7.2 CERE-120 Promises Repair of Damaged Dopaminergic Neurons
6.7.3 AAV-hAADC-2: Another Gene Therapy Contender
6.8 Parthenogenesis (International Stem Cell Corporation): A Promising Outlook for PD Technology
7. Qualitative Analysis of the PD Drug Market, 2016
7.1 SWOT Analysis of the PD Market
7.1.1 Strengths and Weaknesses in the PD Drug Industry in 2016
7.1.2 Opportunities and Threats There from 2016 Onwards
7.2 STEP Analysis of the PD Market
7.2.1 Social Implication of Living with PD
7.2.2 Technological Developments on the Horizon
7.2.3 Economic Pressures: Healthcare Budgeting
7.2.4 Political Issues: Patent Challenges, Data Exclusivity and Regulatory Pathways
8. Research Interviews
8.1 Interview with Dr. Russell Kern (Executive VP, Chief Scientific Officer): International Stem Cell Corporation, California, US
8.1.1 The Overall PD Market
8.1.2 Current Understanding of Stem Cell Therapy
8.1.3 ISCO’s Novel PD Programme
8.1.4 The Potential of Immune-Matching
8.1.5 The Controversy Surrounding Stem Cell Research
8.1.6 The Potential for Parthenogenesis in PD and Other Applications
8.2 Professor Jian Feng PhD, Department of Physiology and Biophysics, University at Buffalo, the State University of New York
8.2.1 A possible Cure
8.2.2 Future Potential: Research
9. Conclusions from the Research and Analysis
9.1 The World PD Market: Predictions to 2026
9.2 Which Therapeutic Class will Dominate the Market in 2026?
9.3 Disease Modification: The Ultimate Goal
9.4 The Future of the Industry and Market for Parkinson’s Medicines
【レポート販売概要】
■ タイトル:パーキンソン病治療薬の世界市場2016-2026■ 英文:Parkinson’s Diseases: World Drug Industry and Market 2016-2026
■ 発行日:2016年5月
■ 調査会社:visiongain
■ 商品コード:VGAIN60623
■ 調査対象地域:グローバル
- マルチコプター・ドローンの世界市場:用途別、ペイロード別、地域別分析The multirotor drones market report offersa complete analysis of the market across the forecast period of five years from 2015 to 2020. It provides an analysis of the factors that drive the market, restrain the growth of the market, and the challenges faced by the industry. The major factors driving the market are the increasing use of drones in law enforcement and for non-military applications. H …
- アセトニトリルの世界市場2018-2022About Acetonitrile Acetonitrile is a simple organic nitrile with chemical formula CH3CN. It is a colorless liquid and is obtained as a byproduct during acrylonitrile manufacturing process. Technavio’s analysts forecast the global acetonitrile market to grow at a CAGR of 4.94% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the …
- ガラス包装の世界市場分析:用途別(食品・飲料、ビール、医薬品)、セグメント予測、-2020The global market for Glass Packaging is expected to reach USD 68.4 billion by 2020, according to a new study by Grand View Research, Inc. Growing beer consumption, especially in parts of Eastern Europe and Asia Pacific is expected to be a key driver for the growth of the market over the next five years. In addition, the increasing preference towards use of glass in packaging of food and beverage, …
- 2014年戦略提言:Pseudomonas診断検査市場The report presents a detailed analysis of the Pseudomonas diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pseudomonas definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - …
- UV(紫外線)安定剤の世界市場:HALS(光安定剤)、UVA(紫外線吸収剤)、消光剤The global UV stabilizer market size, in terms of value, is projected to reach USD 324.4 Million by 2020, registering a CAGR of 6.7% between 2015 and 2020. The growing manufacturing industries, increasing demand for UV stabilizers in the Asia-Pacific region, increasing demand of wood coatings in North America, and continuous product development, expansion, and merger & acquisition activities under …
- Kuwait Energy Company K.S.C.:石油・ガスバリューチェーン分析レポート2013Kuwait Energy Company K.S.C. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Kuwait Energy Company K.S.C." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Kuwait Energy Company K.S.C.”. The report provides key information relating to oil and gas assets of the company along with its operations across the valu …
- カルナウバワックスの世界市場2015Wax, carnauba (CAS 8015-86-9) Market Research Report 2015 aims at providing comprehensive data on Wax, carnauba market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Wax, carnauba description, covers its application areas, manufacturing methods, patterns. It captures Wax, carnauba market trends, pays close attention to Wax, carnauba manufacturers and …
- バイオ外科手術用製品の世界市場:外科用接着剤、止血薬、軟部組織パッチ、合成メッシュ、癒着防止材料、移植骨代用材Biosurgery products are used to aid surgeries and repair weakened and damaged tissues and bones of a body. The biosurgery market is majorly driven by the rising number of surgeries owing to the increasing rate of obesity and other lifestyle disorders, increasing participation in sports leading to sports-related injuries, and growing aging population. However, lack of reimbursement for these produc …
- 民間航空機用酸素系統の世界市場:乗客用酸素系統、乗員用酸素系統、酸素貯蔵装置、酸素供給装置、酸素マスクThe global commercial aircraft oxygen systems (CAOS) market is projected to grow from USD 3.29 Billion in 2015 to USD 4.47 Billion by 2020, at a CAGR of 6.33% during the forecast period, 2015 to 2020. Various factors, such as growing demand for new aircraft deliveries, increasing passenger traffic across the globe, need for lightweight aircraft equipment, and growth opportunities in the aftermarke …
- 世界の商用航空機用電気システム市場動向(2012-2016)TechNavio's analysts forecast the Global Commercial Aircraft Electrical Systems market to grow at a CAGR of 6.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for aircrafts from the APAC region. The Global Commercial Aircraft Electrical Systems market has also been witnessing an increase in the demand for low-maintenance elect …
- 世界の自動車クランクシャフト市場2015The Global Automotive Crankshaft Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Automotive Crankshaft industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automotive Crankshaft market analysis is provided for the international markets including deve …
- 圧力管理式掘削(MPD)サービス の世界市場:一定坑底圧法(CBHP)、マッドキャップ掘削(MCD)、DGD、RFCD技術The global managed pressure drilling services market exhibits a lucrative growth potential of >10% for the next five years. The growth of this market is propelled by the rise in concerns about safety & environment and the increasing capital expenditure in E&P operations being carried out across the globe. The market is further driven by factors such as increasing cost of traditional drilling opera …
- OAaaS:クラウド基盤のEメールサービス企業の比較分析2013(Office Automation as a Service (OAaaS): Email in the Cloud Comparative Analysis of Providers 2013)The solutions for Cloud-based email are many and varied. While many have similar attributes, there a few distinguishing features that set certain providers apart from the pact. This research evaluates leading Office Automation as a Service (OAaaS) provider’s email solutions. The report includes a competitive analysis assessment as well as a comparative analysis by solution and across a standardize …
- 世界のバイオフォトニクス(Biophotonics)市場動向(2012-2016)TechNavio's analysts forecast the Global Biophotonics market to grow at a CAGR of 10.03 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Biophotonics market has also been witnessing the expansion of application. However, the high cost could pose a challenge to the growth of this market. TechNavio's report, t …
- AST/SGOTの市場別検査数および販売予測(2013-2018/体外診断/世界主要国)This new report from Venture Planning Group provides analysis of AST/SGOT testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories PO …